Speaker illustration

Doctor Raphael Wurm

Medical University of Vienna, Vienna (Austria)

RAS Antagonists and beta blockers stabilize HbA1c and improve insulin resistance in patients with diabetes free from cardiac disease

Event: Heart Failure 2018

Topic: Diabetes and the Heart

Session: Diabetes and the Heart


Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles

Event: ESC Congress 2016

Topic: Cardiotoxicity of drugs

Session: Cancer and cardiotoxicity: from bench to bedside


Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Event: ESC Congress 2016

Topic: Pharmacologic therapy

Session: Drug therapy of heart failure


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb